SCHEMBL7199346

SCHEMBL7199346

CCCOOC(=O)/C=C/c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 1/20 0.53
AKR1B1 P15121 1/20 0.53
LMNA P02545 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.49
NPC1 O15118 1/20 0.49
GLA P06280 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
ALDH1A1 P00352 2/20 0.48
KMT2A Q03164 4/20 0.48
HDAC3 O15379 2/20 0.47
TNKS O95271 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HCAR2 Q8TDS4 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
TNKS2 Q9H2K2 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7199354 1.00 AKR1B10 (0.53) AKR1B10AKR1B1LMNAL3MBTL1NPC1
SCHEMBL23702410 0.91 BCHE (0.50) AKR1B10AKR1B1LMNAL3MBTL1NPC1
SCHEMBL23702408 0.91 BCHE (0.50) AKR1B10AKR1B1LMNAL3MBTL1NPC1
SCHEMBL32076 0.88 EGFR (0.55) AKR1B10AKR1B1LMNAHDAC3APP
SCHEMBL28811355 0.88 EGFR (0.55) AKR1B10AKR1B1LMNAHDAC3APP
SCHEMBL32073 0.88 EGFR (0.55) AKR1B10AKR1B1LMNAHDAC3APP
SCHEMBL6244901 0.87 LMNA (0.54) AKR1B10AKR1B1LMNAL3MBTL1NPC1
SCHEMBL6244908 0.87 LMNA (0.54) AKR1B10AKR1B1LMNAL3MBTL1NPC1
Ethylene SCHEMBL28572934 0.84 LMNA (0.51) AKR1B10AKR1B1LMNAL3MBTL1NPC1
Propyl Cinnamate SCHEMBL133146 0.83 AKR1B10 (0.69) AKR1B10AKR1B1LMNAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019197646-A1 PIGMENT COMPOSITION COMPRISING A PIGMENT TREATED WITH PHYTIC ACID SENSIENT COSMETIC TECHNOLOGIES (FR) 2019-10-17 WO disclosed
US-6613340-B2 Substantive UV absorbing organic-soluble quaternary salts of cinnamidoalkylamine are described. Hair, skin and fabric care compositions containing the compounds of formula I. GALAXY SURFACTANTS LTD. (IN) 2003-09-02 US disclosed
US-20030064083-A1 Substantive hydrophobic cationic UV-absorbing compounds GALAXY SURFACTANTS LTD. (IN) 2003-04-03 US disclosed
WO-2002058621-A2 SUBSTANTIVE HYDROPHOBIC CATIONIC UV-ABSORBING COMPOUNDS GALAXY SURFACTANTS LIMITED (IN) 2002-08-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030064083-A1 Substantive hydrophobic cationic UV-absorbing compounds CUTA, ERCC1, SCNN1A AKR1B10 2456/4885AKR1B1 2466/4885LMNA 409/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.